Optima Asset Management has just launched the Optima Healthcare and Biotechnology strategy, which will be managed by five portfolio managers, each specialising in a branch of the sector.

The US-centric long/short strategy will capitalise on a sector that is benefiting from powerful long-term secular tailwinds, CEO D. Dixon Boardman told Opalesque. Innovation is ra